alendronate and arsenic

alendronate has been researched along with arsenic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Endo, N; Huang, Z; Leu, CT; Opas, EE; Ramachandaran, C; Rodan, GA; Rodan, SB; Rutledge, SJ; Schmidt, A; Tanaka, H; Wesolowski, G	1
Ferrari, M; Hu, Z; Nizzero, S; Ramirez, MR; Shen, H; Shi, C; Wu, X; Zhang, G; Zhou, J	1

Other Studies

2 other study(ies) available for alendronate and arsenic

Article	Year
Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate. Proceedings of the National Academy of Sciences of the United States of America, 1996, Apr-02, Volume: 93, Issue:7 Topics: Alendronate; Amino Acid Sequence; Animals; Arsenicals; Bone Marrow Cells; Bone Resorption; Cloning, Molecular; Coculture Techniques; Diphosphonates; Enzyme Inhibitors; Gene Expression; Isoenzymes; Kinetics; Mice; Molecular Sequence Data; Osteoclasts; Protein Tyrosine Phosphatases; Rats; Recombinant Fusion Proteins; Skull; Vanadates	1996
Bone-targeting nanoparticle to co-deliver decitabine and arsenic trioxide for effective therapy of myelodysplastic syndrome with low systemic toxicity. Journal of controlled release : official journal of the Controlled Release Society, 2017, Dec-28, Volume: 268 Topics: Alendronate; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Azacitidine; Bone and Bones; Bone Marrow Cells; Cell Survival; Cells, Cultured; Decitabine; Mice, Transgenic; Myelodysplastic Syndromes; Nanoparticles; Oxides; Phosphatidylethanolamines; Polyethylene Glycols; Tissue Distribution	2017

Article

Year

Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate.

Proceedings of the National Academy of Sciences of the United States of America, 1996, Apr-02, Volume: 93, Issue:7

Topics: Alendronate; Amino Acid Sequence; Animals; Arsenicals; Bone Marrow Cells; Bone Resorption; Cloning, Molecular; Coculture Techniques; Diphosphonates; Enzyme Inhibitors; Gene Expression; Isoenzymes; Kinetics; Mice; Molecular Sequence Data; Osteoclasts; Protein Tyrosine Phosphatases; Rats; Recombinant Fusion Proteins; Skull; Vanadates

1996

Bone-targeting nanoparticle to co-deliver decitabine and arsenic trioxide for effective therapy of myelodysplastic syndrome with low systemic toxicity.

Journal of controlled release : official journal of the Controlled Release Society, 2017, Dec-28, Volume: 268

Topics: Alendronate; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Azacitidine; Bone and Bones; Bone Marrow Cells; Cell Survival; Cells, Cultured; Decitabine; Mice, Transgenic; Myelodysplastic Syndromes; Nanoparticles; Oxides; Phosphatidylethanolamines; Polyethylene Glycols; Tissue Distribution

2017